Significance of the interaction between antizyme 2 and CDR2 under hypoxia in cancer cells
| Project/Area Number |
22590759
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Gastroenterology
|
|---|
| Research Institution | Jikei University School of Medicine |
|---|
Principal Investigator |
MURAI Noriyuki 東京慈恵会医科大学, 医学部, 講師 (60300927)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2012: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
|---|
| Keywords | アンチザイム / ポリアミン / がん / c-Myc / 低酸素 / タンパク質分解 / ユビキチン非依存的分解 / 膵臓がん |
|---|
| Research Abstract |
c-mycis known as the most famous oncogene and encodes c-MYC oncoprotein. c-MYC contributes to cell proliferation, ribosomal biosynthesis, glycolysis and apoptosis. It has been reported that regulation of c-MYC degradation is mediated by ubiquitin-proteasome pathway. However wefound that antizyme 2 protein which regulates cellular polyamine level accelerates degradation of c-MYC by the proteasome ubiquitin-independently. In this study, weshowed that novel ubiquitin independent c-MYC degradation pathway exist in the cells.
|
Report
(4 results)
Research Products
(14 results)
